Market cap
₹88 Cr
Revenue (TTM)
₹30 Cr
P/E Ratio
17.9
P/B Ratio
1.7
Div. Yield
0 %
Quality Score
8/10
Growth Score
2/10
Valuation Score
7/10
Momentum Score
4/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
40.5 %
-
ROCE
42.9 %
-
Industry P/E
59.48
-
EV/EBITDA
8.6
-
Debt to Equity
0.2
-
Book Value
₹17.4
-
EPS
₹5.8
-
Face value
10
-
Shares outstanding
12,571,973
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Invicta Diagnostic
| -11.7 | 4.9 | 9.8 | -- | -- | -- | -- |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Invicta Diagnostic
|
70.0 | 88.0 | 30.1 | 4.9 | -- | 40.5 | 17.9 | 1.7 |
| 1,931.1 | 32,406.6 | 2,890.8 | 546.3 | 23.0 | 23 | 59.8 | 12.4 | |
| 1,472.2 | 39,537.6 | 4,683.4 | 552.3 | 15.6 | 14.9 | 71.1 | 9.6 | |
| 771.0 | 32,332.1 | 4,212.5 | 190.8 | 11.9 | 9.4 | 158.3 | 8.5 | |
| 564.1 | 1,828.7 | 815.3 | 97.5 | 14.9 | 10.2 | 18.8 | 1.8 | |
| 588.5 | 12,198.5 | 1,710.0 | 202.8 | 16.8 | 14.1 | 60.5 | 7.8 | |
| 692.4 | 6,956.7 | 998.9 | 76.8 | -- | 9.2 | 90.5 | 6.1 | |
| 340.2 | 1,765.5 | 325.5 | 35.1 | 18.1 | 15.1 | 49.3 | 6.9 | |
| 584.4 | 9,311.2 | 876.0 | 174.0 | 25.3 | 32.4 | 52.8 | 14.8 | |
| 1,452.5 | 14,953.2 | 857.1 | 187.5 | 31.0 | 20.6 | 79.8 | 14.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Invicta Diagnostic
--
-
Incorporated
2023
-
Chairman
Sanket Vinod Jain
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Invicta Diagnostic Ltd’s IPO? Explore our IPO Details page.
FAQs for Invicta Diagnostic
What is the current share price of Invicta Diagnostic Ltd Today?
The share price of Invicta Diagnostic Ltd is ₹70.00 (NSE) as of 28-Aug-2026 12:04 IST. Invicta Diagnostic Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Invicta Diagnostic Ltd?
The P/E ratio of Invicta Diagnostic Ltd is 17.94 times as on 26-Aug-2026, a 70 discount to its peers’ median range of 59.48 times.
The P/B ratio of Invicta Diagnostic Ltd is 1.71 times as on 26-Aug-2026, a 82 discount to its peers’ median range of 9.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2025 |
0.00 |
0.00 |
What is the 52 Week High and Low of Invicta Diagnostic Ltd?
The 52-week high and low of Invicta Diagnostic Ltd are Rs 105.00 and Rs 0.00 as of 29-Aug-2026.
What is the market cap of Invicta Diagnostic Ltd?
Invicta Diagnostic Ltd has a market capitalisation of ₹ 88 Cr as on 26-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Invicta Diagnostic Ltd?
Before investing in Invicta Diagnostic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.